What we do
Blackbird Laboratories is an independent, nonprofit and next-generation life sciences incubator, dedicated to transforming breakthrough research into scalable, venture-ready biotech companies. We are committed to advancing a better future for patients facing unmet medical needs.
Incubate life sciences
We transform research breakthroughs into scalable, venture-ready biotech companies through operational support, founder-facing resources, and strategic capital. We are dedicated to advancing a better future for patients in need of life-changing therapies.
Accelerate Baltimore biotech
As a nonprofit biotech incubator, we serve as a company creation engine supporting scientists, building new ventures, and attracting top-tier talent.
Build from research to startup
We collaborate with scientists from world-class institutions and early-stage founders in the greater Baltimore region to transform innovative research into life-changing therapies through company creation.
We seek to bridge the gap between pioneering science and industry
Blackbird Laboratories collaborates with world-class institutions and scientific partners to propel our portfolio of innovative technologies toward startup formation through our science and business strategy, program management, and capital.
Ways to engage with us
Academics
Collaborate on pioneering research projects
VCs
Partner on investing in Seed and Series A stage companies
Entrepreneurs
Lead our portfolio companies
Pharma
Initiate strategic collaborations
2 Admin
TEAM
Experienced team
of biotech operators
PROJECTS & COMPANIES
- 19 Funded Projects
- 18 Portfolio Companies
RESOURCES
- $33M Research + Infrastructure
- $37M Investments
LAB SPACE
Incubator opening
in Q1-2026
PARTNERS
Johns Hopkins
UM Baltimore
Lieber Institute
Stanford University
UC San Diego
Foresite Capital
Cure Ventures
Catalio Capital
PTX Capital Decheng Capital
& others